The outcomes of non-invasive prenatal screening at 12 weeks of gestation were consistent with fetal trisomy 18. At 12, 16, and 20 weeks of gestation, fetal ultrasonography showed regular concordant and anatomy biometry. Genetic amniocentesis was declined. The rest of the pregnancy was uncomplicated, and a healthy female infant was shipped at term. Analysis of cfDNA Evaluation of cfDNA from Patient 1 identified a duplicated region on chromosome 18 containing portions of 18p11.31 and 18p11.23 . Evaluation of cfDNA from Patient 3 identified a duplication on chromosome 18 covering an area of 18p11.31 . For both sufferers, maternal DNA from PBMCs was utilized to validate the copy-amount variant through PCR assay and Sanger sequencing .‘Our strong placement in branded generics and growing existence in emerging markets is part of our ongoing diversified pharmaceutical technique, complementing our market-leading proprietary pharmaceutical offerings and pipeline in developed markets. Today, emerging markets represent a lot more than 20 % of Abbott’s total business,’ said Mr. Light. ‘With this deal, the combined Healthcare Solutions and Abbott businesses will become the clear market head in India, with a market share of 7 % approximately,’ said Ajay Piramal, chairman, Piramal Group. ‘This was our collective eyesight and I am pleased that those who find themselves part of Piramal’s Health care Solutions business will recognize this fantasy.’ The Indian Pharmaceutical Marketplace India is among the world’s fastest-developing pharmaceutical markets, due in large component to top quality generics.